A detailed history of Close Asset Management LTD transactions in Illumina, Inc. stock. As of the latest transaction made, Close Asset Management LTD holds 80 shares of ILMN stock, worth $11,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 80 -0.0%
Holding current value
$11,548
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$101.05 - $133.57 $2,021 - $2,671
20 Added 33.33%
80 $8,000
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $30,655 - $35,328
-240 Reduced 80.0%
60 $8,000
Q4 2023

Feb 08, 2024

SELL
$92.79 - $142.53 $139,834 - $214,792
-1,507 Reduced 83.4%
300 $42,000
Q3 2023

Oct 11, 2023

SELL
$128.91 - $192.44 $513,706 - $766,873
-3,985 Reduced 68.8%
1,807 $248,000
Q2 2023

Jul 26, 2023

SELL
$183.43 - $232.67 $63,283 - $80,271
-345 Reduced 5.62%
5,792 $1.09 Million
Q1 2023

Apr 19, 2023

SELL
$193.75 - $232.55 $452,793 - $543,469
-2,337 Reduced 27.58%
6,137 $1.43 Million
Q4 2022

Jan 27, 2023

SELL
$187.24 - $242.74 $275,242 - $356,827
-1,470 Reduced 14.78%
8,474 $1.71 Million
Q3 2022

Oct 26, 2022

SELL
$177.23 - $227.44 $886 - $1,137
-5 Reduced 0.05%
9,944 $1.9 Million
Q2 2022

Jul 29, 2022

SELL
$181.58 - $368.0 $67,003 - $135,792
-369 Reduced 3.58%
9,949 $1.84 Million
Q4 2021

Jan 27, 2022

BUY
$347.28 - $421.83 $467,091 - $567,361
1,345 Added 14.99%
10,318 $3.93 Million
Q3 2021

Nov 04, 2021

BUY
$405.61 - $524.84 $546,356 - $706,959
1,347 Added 17.66%
8,973 $3.64 Million
Q2 2021

Jul 27, 2021

BUY
$372.84 - $481.5 $493,640 - $637,506
1,324 Added 21.01%
7,626 $3.61 Million
Q1 2021

May 07, 2021

BUY
$361.28 - $504.76 $2.28 Million - $3.18 Million
6,302 New
6,302 $2.42 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.